Effects of Physical Activity and Dietary Change in Minority Breast Cancer Survivors
1 other identifier
interventional
42
1 country
1
Brief Summary
This study is testing the effects of exercise and dietary change on weight reduction and biological markers associated with breast cancer risk in breast cancer survivors of Hispanic or African descent (n=45). This is a randomized, crossover pilot and feasibility study to test the effects of a 30-minute circuit-based exercise program that combines resistance training with aerobic exercise in conjunction with a low-fat calorie reduced diet. Participants will be randomized to either an immediate 6-months of exercise and dietary change, or a delayed group who will begin their exercise and dietary change program 6-months after the study begins. Participants in the immediate group will be followed for an additional 6-months in order to evaluate adherence to the exercise and dietary change recommendations. Participants in both groups will exercise at a neighborhood Curves® facility at least 5 times per week for six months and will participate in a series of nutrition education classes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 breast-cancer
Started Jul 2007
Typical duration for phase_2 breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 18, 2008
CompletedFirst Posted
Study publicly available on registry
December 19, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedFebruary 22, 2013
February 1, 2013
2.2 years
December 18, 2008
February 21, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in weight
6 months, 12 months
Intervention adherence
6 months, 12 months
Secondary Outcomes (7)
Barriers to participation
3 months, 6 months, 9 months, 12 months
Predictors of adherence
3 months, 6 months, 9 months, 12 months
Changes in anthropometric measures
3 months, 6 months, 9 months, 12 months
Changes in fitness
3 months, 6 months, 9 months, 12 months
Changes in hormonal biomarkers
3 months, 6 months, 9 months, 12 months
- +2 more secondary outcomes
Study Arms (2)
1
ACTIVE COMPARATORImmediate physical activity and dietary change intervention
2
OTHERDelayed physical activity and dietary change intervention
Interventions
6 months of combined resistance training and aerobic exercise (5 times per week x 30 minutes) plus 6-week nutrition counseling class
Eligibility Criteria
You may qualify if:
- yrs
- Stage 0-IIIa breast cancer
- No evidence of recurrent/metastatic disease
- Hispanic or African descent (African-American or Caribbean)
- BMI \> 25kg/m2
- Sedentary
- Completed surgery, chemotherapy, and radiation therapy ≥ 6 months
- Blood pressure \< 140/90
- HgbA1C \< 8
- LDL cholesterol \< 150
- No uncontrolled comorbidities
- VO2 max normal EKG changes
- Non-smoker
You may not qualify if:
- Evidence of recurrent or metastatic breast cancer
- Uncontrolled co-morbid illness including, but not limited to, type I diabetes mellitus, type II diabetes mellitus, hypertension, symptomatic congestive heart failure, unstable angina pectoris, claudication, cardiac arrhythmia; active pulmonary disease; hypercholesterolemia, neurological condition, ischemic heart disease, cardiac disease, kidney disease, respiration problems, asthma, shortness of breath, physical limitations, abnormal thyroid function, active malignancy, except for squamous or basal cell carcinoma of the skin; receiving active chemotherapy or radiotherapy; or psychiatric illness/social situations that would limit compliance with study requirements
- Currently taking Herceptin therapy, or abnormal echo or MUGA post-Herceptin therapy
- Active tobacco use
- Currently active in an exercise and/or dietary change weight loss program
- If a participant develops a breast cancer recurrence or metastasis during the 12-month study period, her participation in the study will be terminated.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Columbia University
New York, New York, 10032, United States
Related Publications (1)
Delgado-Cruzata L, Zhang W, McDonald JA, Tsai WY, Valdovinos C, Falci L, Wang Q, Crew KD, Santella RM, Hershman DL, Greenlee H. Dietary modifications, weight loss, and changes in metabolic markers affect global DNA methylation in Hispanic, African American, and Afro-Caribbean breast cancer survivors. J Nutr. 2015 Apr;145(4):783-90. doi: 10.3945/jn.114.202853. Epub 2015 Feb 4.
PMID: 25833781DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heather Greenlee, ND, PhD
Columbia University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Department of Epidemiology
Study Record Dates
First Submitted
December 18, 2008
First Posted
December 19, 2008
Study Start
July 1, 2007
Primary Completion
September 1, 2009
Study Completion
November 1, 2012
Last Updated
February 22, 2013
Record last verified: 2013-02